vitiligo is a common skin disorder in which there is a focal failure of pigmentation due to destruction of melanocytes that is thought to be mediated by immunological mechanism.10-30% of patients have history in other relatives. A 5 years old male child was brought to outpatient department of National research institute of Unani medicine for skin disorder Hyderabad, with presenting complaints of hypopigmented patches covering right cheek and periorbital area for from past 3 years, he was treated with topical Unani formulation UNIM001 for the period of 1 year from 0ctober 2020 to October 2021. All the routine blood and urine investigations were done before and after treatment. After 1 year of treatment patient started showing significant clinical results with re-pigmentation of affected area. Therefore, this case study proved successful use of Unani formulation in management of vitiligo.
No takes yet. Share an insight, caveat, or question.
Muzaffer et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: